Location: Home
  • search
  • go
  • Relate News
  • 7/14/2020Long Awaited Chinese Civil Code - Impacts on IPR
  • 7/9/2020Clover Biopharma Receives $66M from CEPI for COVID-19 Vaccine Candidat...
  • 7/8/2020Sinovac Begins Phase III Trial of Its Coronavirus Vaccine in Brazil
  • 7/7/2020SinoPharm Completes New Vaccine Plant in Wuhan, Doubling Capacity
  • 7/3/2020GSK Launches Shingles Vaccines Shingrix in China
  • 7/1/2020China's First COVID-19 mRNA Vaccine Approved for Clinical Trials
  • 6/30/2020China to Initiate Use of a Controversial Covid-19 Vaccine in Its Milit...
  • 6/29/2020Lee's Pharma Gains Chinese Import Approval of Unidrox Prulifloxacin Ta...
  • 6/25/2020Boehringer Ingelheim's China-developed CSF Live Vaccine Approved
  • 6/25/2020Sinovac Receives Approval from China for its Quadrivalent Influenza Va...
  • 6/25/2020China's Vaccine Development Enters Phase III Trial
  • 6/23/2020Clover Biopharma Launches Sixth Chinese COVID-19 Vaccine Trial
  • 6/23/2020Punitive Damages in China's New Civil Code
  • 6/23/2020Bio-Thera's Avastin Biosimilar Application Accepted by NMPA
  • 6/22/2020IMBCAMS Begins Phase II Trial of Its Covid-19 Vaccine
  • 6/18/2020Hua Medicine Successfully Completes SEED (HMM0301), Dorzagliatin's Pha...
  • 6/18/2020Innovent Announces Chinese Approval for BYVASDA (Bevacizumab Biosimila...
  • 6/17/2020Yisheng unveils PIKA adjuvanted recombinant protein vaccine candidate ...
  • 6/17/2020SinoPharm/CNBG Reports Positive Outcome of Early Data on Covid-19 Vacc...
  • 6/16/2020Sinovac Reports Positive Early Data of Its Covid-19 Vaccine
  • 5/21/2020CanSino and Precision NanoSystems Announce Collaboration to Co-Develop...
  • 5/19/2020Qingdao Primedicine and Primary Peptides Enter Exclusive China Partner...
  • 5/6/2020CEPI Signs COVID-19 Vaccine Pact with Clover Bio
  • 4/30/2020NMPA Solicits Comments on Seven Draft Documents on Registration and Po...
  • 4/30/2020CDE Solicits Comments on the Draft Rules for Linked Review and Approva...
  • 4/30/2020NMPA Solicits Comments on the Draft Measures for Control of Vaccine Pr...
  • 4/23/2020Everest Med Approved for Clinical Trial of Sacituzumab in China
  • 4/17/2020Dynavax and Sinovac Announce Collaboration to Develop a COVID-19 Vacci...
  • 4/13/2020China Approves Inactivated COVID-19 Vaccines for Clinical Trials
  • 4/9/2020China Recruits Volunteers for Phase 2 Coronavirus Vaccine Trial
  • Page:18/71 Total number of articles:2126: [First][<<] [16] [17] [18] [19] [20] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group